141 related articles for article (PubMed ID: 9801993)
1. Vitamin D3 inhibits proliferation and increases c-myc expression in fibroblasts from psoriatic patients.
Casado M; Martin M; Muñoz A; Bernal J
J Endocrinol Invest; 1998 Sep; 21(8):520-5. PubMed ID: 9801993
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the inhibitions of proliferation of normal and psoriatic fibroblasts by 1 alpha,25-dihydroxyvitamin D3 and synthetic analogues of vitamin D3 with an oxygen atom in their side chain.
Morimoto S; Imanaka S; Koh E; Shiraishi T; Nabata T; Kitano S; Miyashita Y; Nishii Y; Ogihara T
Biochem Int; 1989 Nov; 19(5):1143-9. PubMed ID: 2561444
[TBL] [Abstract][Full Text] [Related]
3. Dermal fibroblasts are one of the therapeutic targets for topical application of 1alpha,25-dihydroxyvitamin D3: the possible involvement of transforming growth factor-beta induction.
Oyama N; Iwatsuki K; Satoh M; Akiba H; Kaneko F
Br J Dermatol; 2000 Dec; 143(6):1140-8. PubMed ID: 11122013
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor in IMR-90 human fibroblasts and antiproliferative effect of 1,25-dihydroxyvitamin D3.
Stio M; Celli A; Lunghi B; Raugei G; Modesti A; Treves C
Biochem Mol Biol Int; 1997 Dec; 43(6):1173-81. PubMed ID: 9442914
[TBL] [Abstract][Full Text] [Related]
5. Effect of 1,25-(OH)2-vitamin D3 on growth, homologous receptor and c-myc regulation in C3H/10T1/2 cells.
Trydal T; Lillehaug JR; Aksnes L; Aarskog D
Mol Cell Endocrinol; 1990 Dec; 74(3):191-202. PubMed ID: 1965647
[TBL] [Abstract][Full Text] [Related]
6. Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3.
MacLaughlin JA; Gange W; Taylor D; Smith E; Holick MF
Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5409-12. PubMed ID: 2991921
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cell growth, c-myc mRNA, and 1,25-(OH)2 vitamin D3 receptor in C3H/10T1/2 mouse embryo fibroblasts by calcipotriol and 1,25-(OH)2 vitamin D3.
Trydal T; Lillehaug JR; Aksnes L; Aarskog D
Acta Endocrinol (Copenh); 1992 Jan; 126(1):75-9. PubMed ID: 1310564
[TBL] [Abstract][Full Text] [Related]
8. Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium.
Matsumoto K; Hashimoto K; Nishida Y; Hashiro M; Yoshikawa K
Biochem Biophys Res Commun; 1990 Jan; 166(2):916-23. PubMed ID: 2405860
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by 1,25 dihydroxyvitamin D3 of c-myc down-regulation and DNA fragmentation in cytosine arabinoside-induced erythroid differentiation of K562 cells.
Moore DC; Carter DL; Studzinski GP
J Cell Physiol; 1992 Jun; 151(3):539-48. PubMed ID: 1295901
[TBL] [Abstract][Full Text] [Related]
10. Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal and psoriatic keratinocytes.
Hashimoto K; Matsumoto K; Higashiyama M; Nishida Y; Yoshikawa K
Br J Dermatol; 1990 Jul; 123(1):93-8. PubMed ID: 2390499
[TBL] [Abstract][Full Text] [Related]
11. Effects of 1,25-dihydroxyvitamin D3 on proliferation and differentiation of Caco-2 cells.
Halline AG; Davidson NO; Skarosi SF; Sitrin MD; Tietze C; Alpers DH; Brasitus TA
Endocrinology; 1994 Apr; 134(4):1710-7. PubMed ID: 8137734
[TBL] [Abstract][Full Text] [Related]
12. Growth control of human colon-adenocarcinoma-derived Caco-2 cells by vitamin-D compounds and extracellular calcium in vitro: relation to c-myc-oncogene and vitamin-D-receptor expression.
Hulla W; Kállay E; Krugluger W; Peterlik M; Cross HS
Int J Cancer; 1995 Sep; 62(6):711-6. PubMed ID: 7558419
[TBL] [Abstract][Full Text] [Related]
13. The mRNA expression of the human 1,25-dihydroxyvitamin D3 receptor and the c-myc protooncogene in cultured human keratinocytes.
Hanafin NM; Persons KS; Holick MF
In Vitro Cell Dev Biol Anim; 1994 Mar; 30A(3):187-91. PubMed ID: 25939167
[TBL] [Abstract][Full Text] [Related]
14. 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells.
Mitsuhashi T; Morris RC; Ives HE
J Clin Invest; 1991 Jun; 87(6):1889-95. PubMed ID: 1645744
[TBL] [Abstract][Full Text] [Related]
15. Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid.
Sneddon WB; Barry EL; Coutermarsh BA; Gesek FA; Liu F; Friedman PA
Cell Physiol Biochem; 1998; 8(5):261-77. PubMed ID: 9792954
[TBL] [Abstract][Full Text] [Related]
16. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
Koizumi T; Nakao Y; Ishizuka S; Oshida J; Hara N; Ikekawa N; Fijita T
Arch Biochem Biophys; 1990 Feb; 276(2):310-6. PubMed ID: 2407190
[TBL] [Abstract][Full Text] [Related]
17. 1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclones.
Taoka T; Collins ED; Irino S; Norman AW
Mol Cell Endocrinol; 1993 Sep; 95(1-2):51-7. PubMed ID: 8243807
[TBL] [Abstract][Full Text] [Related]
18. 1,25-dihydroxyvitamin D3 inhibits proliferation of IMR-90 human fibroblasts and stimulates pyruvate kinase activity in confluent-phase cells.
Lunghi B; Meacci E; Stio M; Celli A; Bruni P; Nassi P; Treves C
Mol Cell Endocrinol; 1995 Dec; 115(2):141-8. PubMed ID: 8824889
[TBL] [Abstract][Full Text] [Related]
19. Time-course study of 1,25-(OH)2-vitamin D3 induction of homologous receptor and c-myc in nontransformed and transformed C3H/10T1/2 cell clones.
Paatero GI; Trydal T; Karlstedt KA; Aarskog D; Lillehaug JR
Int J Biochem; 1994 Mar; 26(3):367-74. PubMed ID: 8187933
[TBL] [Abstract][Full Text] [Related]
20. 1,25-Dihydroxyvitamin D3 increases collagen production in dermal fibroblasts.
Dobak J; Grzybowski J; Liu FT; Landon B; Dobke M
J Dermatol Sci; 1994 Aug; 8(1):18-24. PubMed ID: 7947488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
